TITLE

Gadd45β expression in chondrosarcoma: A pilot study for diagnostic and biological implications in histological grading

AUTHOR(S)
Zenmyo, Michihisa; Tanimoto, Akihide; Sakakima, Harutoshi; Yokouchi, Masahiro; Nagano, Satoshi; Yamamoto, Takuya; Ishido, Yasuhiro; Komiya, Setsuro; Ijiri, Kosei
PUB. DATE
January 2010
SOURCE
Diagnostic Pathology;2010, Vol. 5, p69
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Background: Although the diagnosis of chondrosarcoma, especially the distinction between enchondroma and low-grade chondrosarcoma or low-grade chondrosarcoma and high-grade chondrosarcoma, is pathologically difficult, differential diagnosis is very important because the treatment strategies for these diseases are completely different. The grading system is crucial in predicting biologic behavior and prognosis, however, exact pathological grading is difficult using only routine examinations because the criteria of the grading system are not necessarily definitive. Growth arrest and DNA damage-inducible protein 45β (GADD45β) is an essential molecule for chondrocytes during terminal differentiation. In the present study, we investigated the immunohistochemical expression of GADD45β in enchondroma, and chondrosarcoma of histological grades I, II, and III, to clarify the diagnostic significance of GADD45β in pathological grading of chondrosarcoma. Methods: Twenty samples (enchondroma = 6, chondrosarcoma grade I = 7, grade II = 6, grade III = 1) were used for immunohistochemical analysis to investigate the expression of GADD45β. Quantitative analysis was performed to compare the number of GADD45β positive cells and pathological grading. Results: Over 70% of the cells in enchondromas expressed GADD45b. On the other hand, the expression of GADD45β decreased significantly according to the histological grade of chondrosarcoma (grade I: 45%; grade II: 13.8%; and grade III: 3.8%). Conclusions: The association of GADD45β expression and pathological grading of chondrosarcoma in the present study suggests that the immunohistochemical study of GADD45β may be a specific diagnostic parameter for chondrosarcoma cell differentiation.
ACCESSION #
55089574

 

Related Articles

  • Atypical solitary enchondroma of radius. Vijay, P. G.; Asharaf, A.; Jayaprakash, U. // Indian Journal of Cancer;Apr-Jun2011, Vol. 48 Issue 2, p276 

    The article presents a case study of an 18-year-old female with pain in the left forearm for about four weeks. The patient undergone a series of examinations, including x-ray and blood test, to detect the disease. She was then differentiated with solitary enchondroma and chondrosarcoma based on...

  • chondrosarcoma.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p443 

    An encyclopedia entry for "chondrosarcoma" which refers to a sarcoma on cartilage is presented.

  • Is there a role for diffusion-weighted MRI (DWI) in the diagnosis of central cartilage tumors? Douis, H.; Jeys, L.; Grimer, R.; Vaiyapuri, S.; Davies, A. // Skeletal Radiology;Jul2015, Vol. 44 Issue 7, p963 

    Objective: To assess if diffusion-weighted MRI (DWI) can differentiate between central enchondromas and chondrosarcomas (CS) and if DWI can distinguish low-grade chondroid lesions from high-grade CS. Materials and methods: Fifty-two patients with central cartilage tumors were included. Patients...

  • Dynamic contrast-enhanced MR imaging for differentiation between enchondroma and chondrosarcoma. Coninck, T.; Jans, L.; Sys, G.; Huysse, W.; Verstraeten, T.; Forsyth, R.; Poffyn, B.; Verstraete, K. // European Radiology;Nov2013, Vol. 23 Issue 11, p3140 

    Objectives: To determine whether dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) can differentiate benign from malignant cartilage tumours compared to standard MRI. To investigate whether a cutoff value could be determined to differentiate enchondroma from low-grade...

  • Curettage and Cryosurgery for Low-grade Cartilage Tumors Is Associated with Low Recurrence and High Function. Mohler, David G.; Chiu, Richard; McCall, David A.; Avedian, Raffi S. // Clinical Orthopaedics & Related Research;Oct2010, Vol. 468 Issue 10, p2765 

    Background: Chondrosarcomas of bone traditionally have been treated by wide or radical excision, procedures that may result in considerable lifelong disability. Grade 1 chondrosarcomas have little or no metastatic potential and are often difficult to distinguish from painful benign enchondromas....

  • D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma. Huse, Jason T.; Pasha, Theresa L.; Zhang, Paul J. // Acta Neuropathologica;Jan2007, Vol. 113 Issue 1, p87 

    Chordomas and low-grade chondrosarcomas of the central nervous system share many histological features, generating, at times, considerable diagnostic difficulty and, not infrequently, requiring immunohistochemical analysis for appropriate classification. While both chordomas and chondrosarcomas...

  • A case of metacarpal chondrosarcoma of the thumb. Miyake, Atsushi; Morioka, Hideo; Yabe, Hiroo; Anazawa, Ukei; Morii, Takeshi; Miura, Keiko; Mukai, Makio; Takayama, Shinichirou; Toyama, Yoshiaki // Archives of Orthopaedic & Trauma Surgery;Jul2006, Vol. 126 Issue 6, p406 

    Enchondroma is the most common primary benign bone tumor of the hand. Chondrosarcomas in this location, however, are extremely rare. It often is difficult to make a histological distinction between benign cartilaginous tumors and low-grade chondro- sarcomas, because enchondromas at this site...

  • Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Bovée, Judith V. M. G.; Hogendoorn, Pancras C. W.; Wunder, Jay S.; Alman, Benjamin A. // Nature Reviews Cancer;Jul2010, Vol. 10 Issue 7, p481 

    As a group, cartilage tumours are the most common primary bone lesions. They range from benign lesions, such as enchondromas and osteochondromas, to malignant chondrosarcoma. The benign lesions result from the deregulation of the hedgehog signalling pathway, which is involved in normal bone...

  • In malignant cartilagenous tumors, immunohistochemical expression of procollagen PC1CP peptide is higher and that of PC2CP lower than in benign cartilaginous lesions. Delaunay-Lemarie, Camille; Vincourt, Jean-Baptiste; Marie, Béatrice; Battaglia-Hsu, Shyue-Fang; Etienne, Stéphanie; Sirveaux, François; Nguyen Thi, Phi; Magdalou, Jacques; Vignaud, Jean-Michel; Gauchotte, Guillaume // Virchows Archiv;Sep2015, Vol. 467 Issue 3, p329 

    Few studies on oncogenesis of chondrosarcoma (CS) are available in the literature. Our previously published experimental evidence suggests that while the C-propeptide of procollagen Iα1 (PC1CP), a component of cartilage, favors tumor progression, the C-propeptide of procollagen IIα1...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics